Technical Analysis for AYLA - Ayala Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Down |
Historical AYLA trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
1,2,3 Pullback Bullish | Bullish Swing Setup | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Fell Below 50 DMA | Bearish | 3.07% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | 3.07% | |
Wide Bands | Range Expansion | 3.07% | |
Gapped Down | Weakness | 3.07% | |
Oversold Stochastic | Weakness | 3.07% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
Up 5% | 2 days ago | |
Up 3% | 2 days ago | |
Up 2% | 2 days ago | |
Up 1% | 2 days ago | |
60 Minute Opening Range Breakdown | 3 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology. It is focused on the development and commercialization of small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Wilmington, DE.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Drugs Oncology Drug Development Wilmington Medical Tests Biomarker Precision Medicine Targeted Therapy Biomarkers Companion Diagnostic Molecule Therapeutics Aggressive Cancers
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Drugs Oncology Drug Development Wilmington Medical Tests Biomarker Precision Medicine Targeted Therapy Biomarkers Companion Diagnostic Molecule Therapeutics Aggressive Cancers
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 28.68 |
52 Week Low | 8.62 |
Average Volume | 40,425 |
200-Day Moving Average | 12.63 |
50-Day Moving Average | 14.51 |
20-Day Moving Average | 17.08 |
10-Day Moving Average | 16.51 |
Average True Range | 1.74 |
ADX | 46.12 |
+DI | 33.83 |
-DI | 23.86 |
Chandelier Exit (Long, 3 ATRs ) | 23.45 |
Chandelier Exit (Short, 3 ATRs ) | 18.17 |
Upper Bollinger Band | 22.66 |
Lower Bollinger Band | 11.50 |
Percent B (%b) | 0.17 |
BandWidth | 65.32 |
MACD Line | 0.10 |
MACD Signal Line | 0.86 |
MACD Histogram | -0.765 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 14.71 | ||||
Resistance 3 (R3) | 14.73 | 14.32 | 14.49 | ||
Resistance 2 (R2) | 14.32 | 13.99 | 14.31 | 14.42 | |
Resistance 1 (R1) | 13.86 | 13.78 | 14.09 | 13.84 | 14.35 |
Pivot Point | 13.45 | 13.45 | 13.57 | 13.44 | 13.45 |
Support 1 (S1) | 13.00 | 13.12 | 13.23 | 12.98 | 12.47 |
Support 2 (S2) | 12.59 | 12.92 | 12.58 | 12.40 | |
Support 3 (S3) | 12.13 | 12.59 | 12.33 | ||
Support 4 (S4) | 12.11 |